- Report
- November 2025
- 101 Pages
North America
From €2998EUR$3,450USD£2,610GBP
- Report
- October 2025
- 89 Pages
Middle East
From €4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 93 Pages
Oman, Middle East
From €4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 85 Pages
Middle East
From €4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4215EUR$4,850USD£3,668GBP
From €4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4215EUR$4,850USD£3,668GBP
- Report
- June 2025
- 96 Pages
Asia Pacific
From €3433EUR$3,950USD£2,988GBP
- Report
- June 2025
- 98 Pages
Europe
From €3433EUR$3,950USD£2,988GBP
- Report
- June 2025
- 88 Pages
North America
From €2998EUR$3,450USD£2,610GBP
- Report
- June 2025
- 80 Pages
Africa, Middle East
From €2998EUR$3,450USD£2,610GBP
- Report
- August 2019
- 264 Pages
Global
From €3472EUR$3,995USD£3,022GBP
- Report
- August 2019
- 488 Pages
Global
From €3475EUR$3,999USD£3,025GBP
- Report
- October 2022
- 213 Pages
Global
From €4697EUR$5,594USD£3,950GBP
- Report
- January 2022
- 249 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2023
- 205 Pages
Global
From €5127EUR$5,899USD£4,462GBP
- Report
- March 2023
- 174 Pages
Global
From €1650EUR$1,899USD£1,436GBP
- Report
- February 2023
- 190 Pages
Global
From €5127EUR$5,899USD£4,462GBP
- Report
- May 2022
- 467 Pages
Global
From €4171EUR$4,799USD£3,630GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more